USFDA conducts inspection of Zydus Lifesciences' Moraiya facility

USFDA conducts inspection of Zydus Lifesciences' Moraiya facility

The inspection was a Pre-Approval Inspection (PAI) for Transdermal Patch products. The inspection concluded with NIL observations

FPJ Web DeskUpdated: Friday, January 27, 2023, 02:54 PM IST
article-image
USFDA conducts inspection of Zydus Lifesciences' Moraiya facility | Image: Zydus Lifesciences Ltd (Representative)

Zydus Lifesciences Limited announced that the USFDA conducted an inspection at the manufacturing facility located at Moraiya, Ahmedabad from 23rd to 27th January, 2023, via an exchange filing.

The inspection was a Pre-Approval Inspection (PAI) for Transdermal Patch products. The inspection concluded with NIL observations.

The company disclosure is pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

India's forex reserves rise for 2nd straight week as Rupee stands firm against dollar

India's forex reserves rise for 2nd straight week as Rupee stands firm against dollar

Infosys Foundation and PPBA successfully conclude first sports conclave

Infosys Foundation and PPBA successfully conclude first sports conclave

Bank of India increases lending rate in April

Bank of India increases lending rate in April

HAL registers highest ever revenue of Rs.26,500 cr in FY 2022-23

HAL registers highest ever revenue of Rs.26,500 cr in FY 2022-23

Interest on post office FDs, savings schemes hiked by 70 bps as bond yields rise

Interest on post office FDs, savings schemes hiked by 70 bps as bond yields rise